Neonatal bacterial sepsis
Document Type
Article
Department
Centre of Excellence in Women and Child Health; Paediatrics and Child Health; Institute for Global Health and Development
Abstract
Neonatal sepsis remains one of the key challenges of neonatal medicine, and together with preterm birth, causes almost 50% of all deaths globally for children younger than 5 years. Compared with advances achieved for other serious neonatal and early childhood conditions globally, progress in reducing neonatal sepsis has been much slower, especially in low-resource settings that have the highest burden of neonatal sepsis morbidity and mortality. By contrast to sepsis in older patients, there is no universally accepted neonatal sepsis definition. This poses substantial challenges in clinical practice, research, and health-care management, and has direct practical implications, such as diagnostic inconsistency, heterogeneous data collection and surveillance, and inappropriate treatment, health-resource allocation, and education. As the clinical manifestation of neonatal sepsis is frequently non-specific and the current diagnostic standard blood culture has performance limitations, new improved diagnostic techniques are required to guide appropriate and warranted antimicrobial treatment. Although antimicrobial therapy and supportive care continue as principal components of neonatal sepsis therapy, refining basic neonatal care to prevent sepsis through education and quality improvement initiatives remains paramount.
Publication (Name of Journal)
The Lancet
DOI
10.1016/S0140-6736(24)00495-1
Recommended Citation
Strunk, T.,
Molloy, E. J.,
Mishra, A.,
Bhutta, Z. A.
(2024). Neonatal bacterial sepsis. The Lancet, 404(10449), 277-293.
Available at:
https://ecommons.aku.edu/coe-wch/108